# A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique

> **NCT01497197** · PHASE3 · TERMINATED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 174 (actual)

## Conditions studied

- Infertility
- Fertility
- Follicle Stimulating Hormone Deficiency

## Interventions

- **DRUG:** GONAL-f®
- **DRUG:** Luveris®
- **BIOLOGICAL:** Recombinant human chorionic gonadotropin (r-hCG)

## Key facts

- **NCT ID:** NCT01497197
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 174 (ACTUAL)
- **Why stopped:** Study was terminated as per sponsor's decision
- **Last updated:** 2015-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01497197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01497197, "A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01497197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*